Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
New Compounding Pharmacy Guidelines Released In Wake of Meningitis Outbreak February 16, 2015 Martha Garcia Add Your Comments Federal regulators have released five guidance documents intended to increase regulatory oversight of compounding pharmacies, a long awaited move taken in the wake of a 2012 fungal meningitis outbreak that was caused by contaminated compounding drugs that were shipped nationwide. The FDA-issued draft guidance documents were issued February 13, nearly three years after a fungal meningitis outbreak linked to products compounded by the New England Compounding Center (NECC) killed more than 60 people and sickened hundreds more throughout the U.S. The guidance documents are applicable to pharmacies, federal facilities, outsourcing facilities and physicians, focusing on outsourcing facility registration, outsourcing facility adverse event reporting, drug repackaging, mixing, diluting and repackaging biological products. The FDA said the documents were issued to help companies comply with important public health provisions. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION A new category of outsourcing facilities was created under the Drug Quality and Security Act (DQSA), which was enacted in response to the deadly fungal meningitis outbreak and provides new laws for how compounding pharmacies should be regulated. Drugs produced by compounders not registered as outsourcing facilities are required to meet other conditions. The first draft document focuses on which entities should register as compounding facilities, clarifying facilities engaged in certain activities, including repackaging human drugs and compounding non-sterile drugs, should register as outsourcing facilities since those drugs will not qualify for exemptions. The second draft guidance concerns how companies may repackage certain human drug products produced by compounding pharmacies. The guidance explains the FDA will not take action against facilities if they follow certain rules, some of which include guidance indicating that a repackaged compounded drug must be a copy of an FDA-approved drug, it must be repackaged at a licensed facility and must be done so in a way that doesn’t “conflict with approved drug product labeling.” The third guidance focused on repackaging biological products and details what the FDA will take action against, such as when state license pharmacy facilities mix, dilute, or repackage specific products without an approved license. The fourth guidance concerns adverse event reporting for compounding pharmacies. It confirms compounding pharmacies are required to report the events to the FDA. The last document is a draft memorandum of understanding detailing the responsibility of the states to investigate and respond to complaints related to compounded human drug products. Compounding Drug Outbreak Repercussions FDA officials issued the recent draft guidance documents to prevent outbreaks like the fungal meningitis outbreak in 2012, which health officials linked to tainted epidural steroid injections compounded by the NECC and sold to many health facilities across the country. A recall was issued by NECC after the tainted steroid were discovered, however the outbreak sickened more than 700 people. More than 17,000 vials of the contaminated steroid were distributed to hospitals and other medical centers nationwide. More than 14,000 patients received the shot. A $100 million settlement was reached by the owners of the NECC, its insurers and some associated medical companies. The settlement will be offered to the victim compensation fund for those who developed meningitis after receiving tainted steroid injections. In December 2014, the Justice Department arrested 14 individuals linked to the outbreak, filing charges and seeking jail time for the executives involved. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Compounding Pharmacy, Epidural Steroid Injection, Fungal Meningitis More Lawsuit Stories Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women September 17, 2025 Bard PowerPort Lawsuit MDL Tops 2,000 Cases September 17, 2025 Investigation into Tesla Door Handle Failures Opened After Children Trapped in Vehicles September 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermLinkedInThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: yesterday) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025) Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: 2 days ago) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025) Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 3 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Investigation into Tesla Door Handle Failures Opened After Children Trapped in Vehicles September 17, 2025
Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: yesterday) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)
Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: 2 days ago) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)
Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 3 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)